Rheumatology
579 articles · 21 journals
Journals in this subcategory (21)
- Annals of the Rheumatic Diseases · Elsevier (86)
- Seminars in Arthritis and Rheumatism · Elsevier (76)
- Osteoarthritis and Cartilage · Elsevier (57)
- Best Practice & Research Clinical Rheumatology · Elsevier (52)
- The Lancet Rheumatology · Elsevier (47)
- Reumatología Clínica · Elsevier (45)
- Rheumatic Disease Clinics of North America · Elsevier (37)
- Arthritis Care and Research · Wiley (33)
- Joint Bone Spine · Elsevier (31)
- Revue du Rhumatisme · Elsevier (31)
- International Journal of Rheumatic Diseases · Wiley (28)
- Rheumatology and Autoimmunity · Wiley (21)
- The Egyptian Rheumatologist · Elsevier (16)
- ACR Open Rheumatology · Wiley (11)
- Nature Reviews Rheumatology · Springer Nature (8)
- Advances in Rheumatology · Springer Nature (0)
- Arthritis Research & Therapy · Springer Nature (0)
- BMC Rheumatology · Springer Nature (0)
- Clinical Rheumatology · Springer Nature (0)
- Current Rheumatology Reports · Springer Nature (0)
- Egyptian Rheumatology and Rehabilitation · Springer Nature (0)
- ERN ReCONNET–SLICC–SLEuro consensus on the therapeutic management of rare systemic lupus erythematosus manifestations (part 2)
- Relevance of the 2025 ESC guidelines for the diagnosis and management of myocarditis and pericarditis for systemic autoimmune rheumatic diseases
- Oligoarthritis, hypomagnesaemia, and primary amenorrhea in a patient with diabetes
- Genomic ascertainment of systemic autoinflammatory diseases: a retrospective cohort study in two population-based biobanks
- Rare genetic conditions can be both underdiagnosed and overdiagnosed
- Spatial frequency domain imaging for assessment of skin fibrosis in systemic sclerosis: a prospective cohort study
- Redefining long-term success in systemic sclerosis
- Long-term evaluation of the effectiveness and safety of autologous haematopoietic stem-cell transplantation for systemic sclerosis (NISSC1-LTE): a cohort study
- CAR T cells in autoimmunity: safety first
- Predicting cytokine release syndrome after CAR T-cell therapy for autoimmune diseases
- Restoring immune tolerance in rheumatoid arthritis through PD-1 agonism
- Beyond vasomotor symptoms: reframing musculoskeletal health in the Women's Health Strategy
- Operationalising the physician problematic disease criterion in difficult-to-treat inflammatory arthritis: the case for physician acceptable symptom state
- Colitis in a patient with SLE treated with CAR T cells: LICATS or not?
- Low TRIM21 signal in Sjögren's: biomarker or analytical interference?
- Low TRIM21 signal in Sjögren's: biomarker or analytical interference? – Authors' reply
- Research in Brief
- Predicting prevalence and severity of cytokine release syndrome after CAR T-cell therapy in patients with autoimmune disease: a retrospective cohort study
- Minimal residual disease flow cytometry of peripheral blood B-cell subsets in patients with idiopathic inflammatory myopathies following rituximab therapy: a single-centre, retrospective cohort study
- Efficacy and safety of rozanolixizumab in severe fibromyalgia: a phase 2A randomised, double-blind, placebo-controlled, multicentre trial
- Cellular and proteomic changes following administration of peresolimab in patients with rheumatoid arthritis: a post-hoc analysis of a randomised phase 2a trial
- CAR T cells for autoimmune diseases: 2026 update of the EBMT–ISCT–JACIE practice harmonisation and consensus recommendations
- Innovative therapies in rheumatoid arthritis: CAR T cells and bispecific antibodies
- A diagnostic enigma: when arteries and muscles collide
- Effect of ethnicity on response to treatment escalation in patients with systemic lupus erythematosus from the British Isles Lupus Assessment Group Biologics Register (BILAG-BR): a longitudinal cohort study
- The IgG4ward! Foundation guidelines on the treatment of IgG4-related disease
- Efficacy and safety of obinutuzumab β in patients with active systemic lupus erythematosus: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
- Harmonising difficult-to-manage and complex-to-manage psoriatic arthritis: from divergent prevalence estimates to reproducible, mechanism-aware phenotypes
- Efficacy of methotrexate treatment for joint manifestations of PAPA syndrome
- Psoriatic arthritis, fibromyalgia and osteoporosis: A tricky therapeutic approach in familial hypercholesterolemia